165 related articles for article (PubMed ID: 29933706)
1. Liquid biopsies to optimize therapeutic efficacy in unresponsive lung cancer patients.
Santarpia M; Funel N; Ali A; Giovannetti E
Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):761-763. PubMed ID: 29933706
[No Abstract] [Full Text] [Related]
2. Detection of Discrepant Driver Mutations in a Patient with Two Synchronous Primary Non-Small Cell Lung Cancers (NSCLCs) with Liquid Biopsy.
Lakis S; Heukamp LC; Griesinger F
J Thorac Oncol; 2017 Nov; 12(11):e186-e188. PubMed ID: 29074212
[No Abstract] [Full Text] [Related]
3. Integrating minimal residual disease monitoring into clinical practice for NSCLC: Is the era upon us?
Li Z; Lu S
Cancer Cell; 2023 Oct; 41(10):1699-1701. PubMed ID: 37816330
[TBL] [Abstract][Full Text] [Related]
4. [Progress of liquid biopsy technique and clinical application in lung cancer].
Wang NF; Yang Y; Chen SF
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Nov; 41(11):881-883. PubMed ID: 30423633
[No Abstract] [Full Text] [Related]
5. The liquid biopsy: a tool for a combined diagnostic and theranostic approach for care of a patient with late-stage lung carcinoma presenting with bilateral ocular metastases.
Bouhlel L; Hofman V; Maschi C; Ilié M; Allégra M; Marquette CH; Audigier-Valette C; Thariat J; Hofman P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1087-1092. PubMed ID: 29069959
[TBL] [Abstract][Full Text] [Related]
6. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
7. Thoracic inspirations: advances in the diagnosis, staging, and treatment of non-small-cell lung cancer.
Toloza EM
Cancer Control; 2014 Jan; 21(1):4-5. PubMed ID: 24357735
[No Abstract] [Full Text] [Related]
8. [Advances in Liquid Biopsy and its Clinical Application in the Diagnosis
and Treatment of Non-small Cell Lung Cancer].
Zheng D; Chen H
Zhongguo Fei Ai Za Zhi; 2016 Jun; 19(6):394-8. PubMed ID: 27335304
[TBL] [Abstract][Full Text] [Related]
9. Practice guidelines for non-small cell lung cancer.
Cameron R; Fringer J; Taylor C; Gilden CR; Figlin RA
Cancer J Sci Am; 1996; 2(3A Suppl):S61-8. PubMed ID: 9166525
[No Abstract] [Full Text] [Related]
10. Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era.
Palmieri M; Frullanti E
Med Sci (Basel); 2023 Jan; 11(1):. PubMed ID: 36649045
[TBL] [Abstract][Full Text] [Related]
11. [Non-small cell lung cancer (NSCLC)].
Yoshimori K
Nihon Rinsho; 2002 May; 60 Suppl 5():294-7. PubMed ID: 12101676
[No Abstract] [Full Text] [Related]
12. [Non-small cell lung cancer].
Yoshimura A; Niitani H
Ryoikibetsu Shokogun Shirizu; 1994; (4):100-3. PubMed ID: 8007089
[No Abstract] [Full Text] [Related]
13. Non-small-cell lung cancer: then and now.
Schiller JH; Gandara DR; Goss GD; Vokes EE
J Clin Oncol; 2013 Mar; 31(8):981-3. PubMed ID: 23401450
[No Abstract] [Full Text] [Related]
14. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
D'Addario G; Felip E;
Ann Oncol; 2008 May; 19 Suppl 2():ii39-40. PubMed ID: 18456762
[No Abstract] [Full Text] [Related]
15. Oligometastatic non-small cell lung cancer: Where do we go next?
Malik N; Palma D
Lung Cancer; 2017 Apr; 106():145-147. PubMed ID: 28062090
[No Abstract] [Full Text] [Related]
16. Tumor size does not predict pathological complete response rates after pre-operative chemoradiotherapy for non-small cell lung cancer.
Vos CG; Dahele M; Dickhoff C; Senan S; Thunnissen E; Hartemink KJ
Acta Oncol; 2013 Apr; 52(3):676-8. PubMed ID: 23098694
[No Abstract] [Full Text] [Related]
17. Natural history of stage I lung cancer.
Reich J; Asaph J
Chest; 2007 Dec; 132(6):2062; author reply 2062-3. PubMed ID: 18079253
[No Abstract] [Full Text] [Related]
18. Rapid biomarker testing for improved clinical decision-making in nonsmall cell lung cancer.
Kaplan EH
MLO Med Lab Obs; 2017 Jun; 49(6):12-4, 16-8. PubMed ID: 29952196
[No Abstract] [Full Text] [Related]
19. Neuroendocrine Cancer of the Lung: A Diagnostic Puzzle.
Derks JL; Speel EJ; Thunnissen E; van Suylen RJ; Buikhuisen WA; van Velthuysen ML; Dingemans AM
J Thorac Oncol; 2016 Mar; 11(3):e35-8. PubMed ID: 26723240
[TBL] [Abstract][Full Text] [Related]
20. The role of cytology in molecular testing and personalized medicine in lung cancer: A clinical perspective.
Young K; da Cunha Santos G; Card P; Leighl N
Cancer Cytopathol; 2019 Feb; 127(2):72-78. PubMed ID: 30512242
[No Abstract] [Full Text] [Related]
[Next] [New Search]
